MOLECULAR STUDIES OF FC RECEPTORS FOR IMMUNOGLOBULIN E
免疫球蛋白 E FC 受体的分子研究
基本信息
- 批准号:2061010
- 负责人:
- 金额:$ 22.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-08-01 至 1995-02-28
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assay antibody formation antibody receptor basophils binding proteins chemical structure function gene expression genetic manipulation genetic recombination histamine release hypersensitivity immunoglobulin E immunoregulation laboratory mouse laboratory rabbit mast cell membrane proteins messenger RNA molecular cloning protein structure site directed mutagenesis tissue /cell culture transfection
项目摘要
The IgE receptor on mast cells and basophils (Fcepsilone R-I) is
directly involved in the IgE-mediated activation of these cells.
Recently, cDNA coding for the alpha-subunit of the rat Fcepsilone
R-I (Fcepsilone R-Ialpha) has been cloned. RNA heterogeneity was
subsequently detected, suggesting the presence of variants of Fc
epsilone R-Ialpha, including the possible presence of intracellular
forms and secretory truncated forms of Fc epsilone R-Ialpha. A new
IgE-binding protein, epsilone BP, was found to contain interesting
structural features, but its function is yet to be defined. In
this research program, we will continue our studies of both Rc
epsilone R-I and epsilone BP.
First, structure-function relationship of rodent Fcepsilone R-I
alpha will be established. Expression of cloned cDNA in mammalian
cells by gene transfection will be conducted. Expression of both
the surface membrane-bound form and soluble form of the receptor
will be pursued. Mutant Fc epsilone R-I alpha in normal rat mast
cells. Various protein products predicted from the cDNA cloning
results, including the intracellular and secetory truncated forms
of Fcepsilone R-I alphs will be generated for structure-function
analysis to identify structural elements in FcepsiloneR-Ialphs that
are involved in binding to IgE.
Second, various forms of FcepsiloneR-Ialpha will be identified.
RNase protection analysis and polymerase chain reaction methodology
will be employed to identify various RNA forms related to
FcepsiloneR-Ialpha in normal rat mast cells. Various protein
products predicted from the cDNA cloning results, including the
intracellular and secretory truncated forms of FcepsiloneR-Ialpha
will be detected in RBL cells. Genomic DNA coding for mouse
FCepsiloneR-Ialpha will be cloned and used to extend the above
analysis to the mouse system.
Third, function of the newly defiend IgE-binding protein
(epsiloneBP) will be delineated. Cell types expressing epsilone
and the location of epsilone in cells will be identified. If it
is established that epsilone is not a cell suface receptor, its
role as a soluble protein, regulating IgE synthesis or histamine
release form mast cells and basophils will be explored.
The long-term goals of this research are: 1) establishment of
structure, function and regulation of key components of the IgE
system; and 2) development of therapeutic methods for the treatment
of human allergic disorders.
肥大细胞和嗜碱性粒细胞上的IgE受体(Fcepsilone R-I)是
直接参与IgE介导的这些细胞的活化。
最近,编码大鼠Fcepsilone α-亚基的cDNA
R-I(Fcepsilone R-Ialpha)已被克隆。 RNA异质性是
随后检测到,表明存在Fc的变体
epsilone R-I α,包括可能存在的细胞内
形式和分泌截短形式的Fc ε R-I α。 一个新
IgE结合蛋白,epsilone BP,被发现含有有趣的
结构特征,但其功能尚未明确。 在
在这项研究计划中,我们将继续研究Rc
epsilone R-I和epsilone BP。
第一,啮齿动物Fecepsilone R-I的结构-功能关系
阿尔法将成立。 克隆的cDNA在哺乳动物中的表达
将进行基因转染的细胞。 两者的表达
受体的表面膜结合形式和可溶形式
将被追究。 正常大鼠肥大细胞中的突变Fc ε R-I α
细胞 从cDNA克隆预测的各种蛋白质产物
结果,包括细胞内和分泌截短形式
将生成的Fcepsilone R-I样品用于结构-功能分析
分析,以鉴定
与IgE结合有关。
第二,将鉴定各种形式的FcepsiloneR-Ialpha。
RNA酶保护分析和聚合酶链反应方法学
将被用来鉴定各种RNA形式,
正常大鼠肥大细胞中的FcepsiloneR-I α。 各种蛋白质
从cDNA克隆结果预测的产物,包括
胞内和分泌性截短形式的FcepsiloneR-I α
将在RBL细胞中检测到。 编码小鼠的基因组DNA
FCepsiloneR-Ialpha将被克隆并用于扩展上述
对鼠标系统的分析。
第三,新定义的IgE结合蛋白的功能
(epsiloneBP)将被描绘。 表达epsilone的细胞类型
并将鉴定ε-酮在细胞中的位置。 如果
已经确定ε-酮不是细胞表面受体,
作为一种可溶性蛋白,调节IgE合成或组胺
将探索肥大细胞和嗜碱性粒细胞的释放。
本研究的远期目标是:1)建立
IgE关键成分的结构、功能和调节
系统;和2)治疗方法的发展,用于治疗
人类过敏性疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FU-TONG LIU其他文献
FU-TONG LIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FU-TONG LIU', 18)}}的其他基金
DEVELOPMENT OF NONHUMAN PRIMATE MODELS OF ATOPIC DERMATITIS
特应性皮炎非人灵长类动物模型的开发
- 批准号:
8357349 - 财政年份:2011
- 资助金额:
$ 22.34万 - 项目类别:
Galectin-3 in regulation of allergic skin inflammation
Galectin-3 调节过敏性皮肤炎症
- 批准号:
7785910 - 财政年份:2010
- 资助金额:
$ 22.34万 - 项目类别:
DEVELOPMENT OF NONHUMAN PRIMATE MODELS OF ATOPIC DERMATITIS
特应性皮炎非人灵长类动物模型的开发
- 批准号:
8172632 - 财政年份:2010
- 资助金额:
$ 22.34万 - 项目类别:
Galectin-3 in regulation of allergic skin inflammation
Galectin-3 调节过敏性皮肤炎症
- 批准号:
8401847 - 财政年份:2010
- 资助金额:
$ 22.34万 - 项目类别:
Galectin-3 in regulation of allergic skin inflammation
Galectin-3 调节过敏性皮肤炎症
- 批准号:
8206814 - 财政年份:2010
- 资助金额:
$ 22.34万 - 项目类别:
Galectin-3 in regulation of allergic skin inflammation
Galectin-3 调节过敏性皮肤炎症
- 批准号:
8013555 - 财政年份:2010
- 资助金额:
$ 22.34万 - 项目类别:
Regulation of Skin Wound Epithelialization by Galectin-3
Galectin-3 调节皮肤伤口上皮化
- 批准号:
7470573 - 财政年份:2007
- 资助金额:
$ 22.34万 - 项目类别:
Regulation of Skin Wound Epithelialization by Galectin-3
Galectin-3 调节皮肤伤口上皮化
- 批准号:
7315928 - 财政年份:2007
- 资助金额:
$ 22.34万 - 项目类别:
Validation of Galectin-3 as a Target in Cancer Therapy
Galectin-3 作为癌症治疗靶点的验证
- 批准号:
6640748 - 财政年份:2002
- 资助金额:
$ 22.34万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 22.34万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 22.34万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 22.34万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 22.34万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 22.34万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 22.34万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 22.34万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 22.34万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 22.34万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 22.34万 - 项目类别: